What’s Next in RCC Diagnostics? Ultrasound, Biopsy, AI, and Treating Small Renal Masses

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Drs. Dan Joyce and Sam Chang, of Vanderbilt University Medical Center, explore the evolving management of small renal masses, focusing on diagnostic approaches, imaging strategies, biopsy decisions, and how patient and tumor characteristics influence treatment. They discuss the limitations of current tools, the role of biomarkers like KIM-1, and how future innovations—including AI—may personalize care for patients with kidney tumors.

#kidneycancer #renalcellcarcinoma #biomarkers #urology #cancerresearch
Category
Urology
Be the first to comment

Up Next